PDSB

PDS Biotechnology Corp

Healthcare · Biotechnology

$75.72 sample

+0.28 (+0.37%) 1D

Market cap

$450.4B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-07

Alerts

8

Price$75.72 +7.99% 3M daily closessample

76.2369.56

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider sell: General Counsel
Sep 17INSInsider sell: EVP, Operations
Sep 10INSInsider sell: Director
Sep 07SECForm 144 filed
Aug 31SEC10-Q filed
Aug 20SECDEF 14A filed
Aug 12INSInsider sell: Chief Financial Officer
Aug 07INSInsider sell: Chief Executive Officer

Sign up to see the real PDSB record →

Company facts

SEC EDGAR registration

Name: PDS Biotechnology Corp
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -47sample, -100 to +100
Reporting currency: USD

Who is positioning in PDSB

sample

Insiders: 33 insider transactions over 90 days, net selling, $767.4M
Congress: 2 members traded over 90 days
Institutions · 13F: 44 funds hold $9.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$20.7B +17.2% y/y

Q4 2024Q3 2026

Inventory$12.5B +7.2% y/y

Q4 2024Q3 2026

Accounts receivable$9.6B +8.7% y/y

Q4 2024Q3 2026

Total debt$25.8B +18.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $352.7B -7.9% 3M
Sample peer B: $53.3B +1.0% 3M
Sample peer C: $358.9B -0.1% 3M
Sample peer D: $274.5B -11.2% 3M
Sample peer E: $404.1B -4.1% 3M